标题
The use of nanoparticles for targeted drug delivery in non-small cell lung cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-03-09
DOI
10.3389/fonc.2023.1154318
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
- (2021) Mingying Xie et al. Frontiers in Oncology
- The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
- (2021) Jun Wu Journal of Personalized Medicine
- Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
- (2021) Jie Zhang et al. Cancer Communications
- New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies
- (2020) Lin Zhao et al. JOURNAL OF DRUG TARGETING
- Clinical failure of nanoparticles in cancer: mimicking nature's solutions
- (2020) Pablo Hernández-Camarero et al. Nanomedicine
- Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival
- (2020) Idoroenyi Amanam et al. Journal of Thoracic Disease
- Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
- (2020) M. Shi et al. ANNALS OF ONCOLOGY
- Keeping Nanomedicine on Target
- (2020) Wei Zhang et al. NANO LETTERS
- pH-Responsive Polymer Nanoparticles for Drug Delivery
- (2019) Nayeleh Deirram et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic Markers
- (2019) Konrad Pawelczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cell Membrane Coating Nanotechnology
- (2018) Ronnie H. Fang et al. ADVANCED MATERIALS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK/mTOR and JNK pathways
- (2018) Chen Li et al. Biochemistry and Cell Biology
- Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN)
- (2018) Bei Xu et al. MEDICINE
- The combined administration of parthenolide and ginsenoside CK in long circulation liposomes with targeted tLyp-1 ligand induce mitochondria-mediated lung cancer apoptosis
- (2018) Xin Jin et al. Artificial Cells Nanomedicine and Biotechnology
- Lung Cancer Biomarkers
- (2017) Pamela Villalobos et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- LHRH-Targeted Drug Delivery Systems for Cancer Therapy
- (2017) Xiaoning Li et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Effects of engineered nanoparticles on the innate immune system
- (2017) Yuanchang Liu et al. SEMINARS IN IMMUNOLOGY
- Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo
- (2017) Sheng Tan et al. Drug Design Development and Therapy
- Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway
- (2017) Minting Lin et al. Oncotarget
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
- (2016) Yuko Nakamura et al. BIOCONJUGATE CHEMISTRY
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Cytosolic phospholipase A2: physiological function and role in disease
- (2015) Christina C. Leslie JOURNAL OF LIPID RESEARCH
- Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
- (2015) Wing-Hin Lee et al. Asian Journal of Pharmaceutical Sciences
- Delivery strategies for sustained drug release in the lungs
- (2014) Cristina Loira-Pastoriza et al. ADVANCED DRUG DELIVERY REVIEWS
- A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
- (2014) Hee Kyung Ahn et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy
- (2014) Shenbagamoorthy Sundarraj et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors
- (2014) Puey Ling Chia et al. Clinical Epidemiology
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA
- (2011) Oleh Taratula et al. JOURNAL OF DRUG TARGETING
- Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors
- (2009) W. T. Lim et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now